{"id":"https://openalex.org/W1964480573","doi":"https://doi.org/10.1186/1471-2407-10-626","title":"COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer","display_name":"COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer","publication_year":2010,"publication_date":"2010-11-15","ids":{"openalex":"https://openalex.org/W1964480573","doi":"https://doi.org/10.1186/1471-2407-10-626","mag":"1964480573","pmid":"https://pubmed.ncbi.nlm.nih.gov/21078168","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2993681"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2407-10-626","doi":"https://doi.org/10.1186/1471-2407-10-626","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-10-626","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-10-626","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-10-626","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017672961","display_name":"Sharon Anneve Glynn","orcid":"https://orcid.org/0000-0003-1459-2580","observed_orcids":["https://orcid.org/0000-0003-1459-2580"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon A Glynn","raw_affiliation_strings":["Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032145876","display_name":"Robyn L. Prueitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robyn L Prueitt","raw_affiliation_strings":["Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002365439","display_name":"Lisa A. Ridnour","orcid":"https://orcid.org/0000-0001-9446-8349","observed_orcids":["https://orcid.org/0000-0001-9446-8349"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa A Ridnour","raw_affiliation_strings":["Radiation Biology Branch, CCR, NCI, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Biology Branch, CCR, NCI, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053260313","display_name":"Brenda J. Boersma","orcid":"https://orcid.org/0000-0002-8992-2735","observed_orcids":["https://orcid.org/0000-0002-8992-2735"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda J Boersma","raw_affiliation_strings":["Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113519923","display_name":"Tiffany M Dorsey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiffany M Dorsey","raw_affiliation_strings":["Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044929543","display_name":"David A. Wink","orcid":"https://orcid.org/0000-0002-5652-7480","observed_orcids":["https://orcid.org/0000-0002-5652-7480"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A Wink","raw_affiliation_strings":["Radiation Biology Branch, CCR, NCI, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Biology Branch, CCR, NCI, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072175033","display_name":"Julie E. Goodman","orcid":"https://orcid.org/0000-0002-2199-1646","observed_orcids":["https://orcid.org/0000-0002-2199-1646"]},"institutions":[{"id":"https://openalex.org/I4210100879","display_name":"Gradient (United States)","ror":"https://ror.org/014qf4206","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100879"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie E Goodman","raw_affiliation_strings":["Gradient Corporation, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gradient Corporation, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210100879"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052087705","display_name":"Harris G. Yfantis","orcid":"https://orcid.org/0009-0004-3076-9627","observed_orcids":["https://orcid.org/0009-0004-3076-9627"]},"institutions":[{"id":"https://openalex.org/I4210140381","display_name":"Baltimore VA Medical Center","ror":"https://ror.org/036a0e562","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210111569","https://openalex.org/I4210140381","https://openalex.org/I4210163125"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harris G Yfantis","raw_affiliation_strings":["Pathology and Laboratory Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology and Laboratory Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, MD, USA","institution_ids":["https://openalex.org/I4210140381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049179462","display_name":"Dong Heun Lee","orcid":"https://orcid.org/0000-0002-1860-3446","observed_orcids":["https://orcid.org/0000-0002-1860-3446"]},"institutions":[{"id":"https://openalex.org/I4210140381","display_name":"Baltimore VA Medical Center","ror":"https://ror.org/036a0e562","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210111569","https://openalex.org/I4210140381","https://openalex.org/I4210163125"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong H Lee","raw_affiliation_strings":["Pathology and Laboratory Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology and Laboratory Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, MD, USA","institution_ids":["https://openalex.org/I4210140381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027170042","display_name":"Stefan Ambs","orcid":"https://orcid.org/0000-0001-7651-9309","observed_orcids":["https://orcid.org/0000-0001-7651-9309"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stefan Ambs","raw_affiliation_strings":["Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Human Carcinogenesis, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, Maryland (MD), USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5027170042"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":3.5006,"has_fulltext":true,"cited_by_count":80,"citation_normalized_percentile":{"value":0.91465081,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"626","last_page":"626"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.921999990940094},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8899999856948853},{"id":"https://openalex.org/keywords/estrogen-receptor-negative-breast-cancer","display_name":"estrogen receptor-negative breast cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/disease-specific-survival","display_name":"disease-specific survival","score":0.9049999713897705},{"id":"https://openalex.org/keywords/bad-phosphorylation","display_name":"Bad phosphorylation","score":0.9129999876022339},{"id":"https://openalex.org/keywords/akt-pathway","display_name":"AKT pathway","score":0.6190000176429749},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.783401608467102},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.7517709732055664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7446058988571167},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7016196250915527},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.6451074481010437},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6258946657180786},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5860564708709717},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4825100898742676},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.47995904088020325},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4027985632419586},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.15970632433891296},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11043515801429749},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016158","descriptor_name":"Genes, p53","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D047628","descriptor_name":"Estrogen Receptor alpha","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D051025","descriptor_name":"bcl-Associated Death Protein","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D053453","descriptor_name":"Caspase 9","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/1471-2407-10-626","doi":"https://doi.org/10.1186/1471-2407-10-626","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-10-626","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-10-626","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmid:21078168","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21078168","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2993681","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2993681/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3d7292d9914f49b29b2421de8c8debf3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3d7292d9914f49b29b2421de8c8debf3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 10, Iss 1, p 626 (2010)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1471-2407-10-626","doi":"https://doi.org/10.1186/1471-2407-10-626","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-10-626","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-10-626","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320312041","display_name":"Health Research Board","ror":"https://ror.org/003hb2249"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1964480573.pdf","grobid_xml":"https://content.openalex.org/works/W1964480573.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1754585763","https://openalex.org/W1783009344","https://openalex.org/W1863087187","https://openalex.org/W1968442275","https://openalex.org/W1969780570","https://openalex.org/W1976565595","https://openalex.org/W1981672008","https://openalex.org/W1984754931","https://openalex.org/W1988747916","https://openalex.org/W2001529630","https://openalex.org/W2023648132","https://openalex.org/W2041140906","https://openalex.org/W2046917725","https://openalex.org/W2049475256","https://openalex.org/W2050683019","https://openalex.org/W2051135482","https://openalex.org/W2063284947","https://openalex.org/W2064242629","https://openalex.org/W2077371239","https://openalex.org/W2082770517","https://openalex.org/W2083573754","https://openalex.org/W2087739228","https://openalex.org/W2096410299","https://openalex.org/W2097669235","https://openalex.org/W2100155438","https://openalex.org/W2110521199","https://openalex.org/W2112893608","https://openalex.org/W2114808102","https://openalex.org/W2117115931","https://openalex.org/W2129377268","https://openalex.org/W2131994307","https://openalex.org/W2152196126","https://openalex.org/W2157158866","https://openalex.org/W2162047243","https://openalex.org/W2169532459","https://openalex.org/W2182021524","https://openalex.org/W2266153359","https://openalex.org/W2319962899"],"related_works":["https://openalex.org/W1984754931","https://openalex.org/W2121721599","https://openalex.org/W2363491195","https://openalex.org/W7096499784","https://openalex.org/W2126380540","https://openalex.org/W2096410299","https://openalex.org/W1980512156","https://openalex.org/W2240455084","https://openalex.org/W2059426597","https://openalex.org/W6941172497"],"abstract_inverted_index":{"BACKGROUND:":[0],"Inducible":[1],"cyclooxgenase-2":[2],"(COX-2)":[3],"is":[4,11,32,211,218],"commonly":[5],"overexpressed":[6],"in":[7,65,118,175,205,242],"breast":[8,25,69,115,138,209,247],"tumors":[9,180,210],"and":[10,28,37,41,49,55,60,73,86,91,106,135,164,178,188,197,207,217,230,245],"a":[12,219],"target":[13],"for":[14],"cancer":[15,26,116,139,248],"therapy.":[16],"Here,":[17],"we":[18],"studied":[19],"the":[20,82,102,147,176,190,233,243],"association":[21,31],"of":[22,57,68,149,186,189,203,221,232],"COX-2":[23,85,105,110,155,173,204],"with":[24,114,153,183,213],"survival":[27,90,151],"how":[29],"this":[30],"influenced":[33],"by":[34],"tumor":[35,87],"estrogen":[36,50],"HER2":[38,48,136],"receptor":[39,51],"status":[40],"Akt":[42,187,192,214,234],"pathway":[43,215,235],"activation.":[44],"METHODS:":[45],"Tumor":[46],"COX-2,":[47],"\u03b1":[52],"(ER)":[53],"expression":[54,174],"phosphorylation":[56,185],"Akt,":[58],"BAD,":[59],"caspase-9":[61,198],"were":[62,78,98,161],"analyzed":[63],"immunohistochemically":[64],"248":[66],"cases":[67],"cancer.":[70],"Spearman's":[71],"correlation":[72],"multivariable":[74,92],"logistic":[75],"regression":[76,96],"analyses":[77,97],"used":[79,99],"to":[80,100],"examine":[81,101],"relationship":[83,103],"between":[84,104],"characteristics.":[88],"Kaplan-Meier":[89],"Cox":[93],"proportional":[94],"hazards":[95],"disease-specific":[107],"survival.":[108],"RESULTS:":[109],"was":[111,156],"significantly":[112,182],"associated":[113,152,212],"outcome":[117],"ER-negative":[119,163,177,206,244],"[Hazard":[120],"ratio":[121],"(HR)":[122],"=":[123,141,167],"2.72;":[124],"95%":[125,143,169],"confidence":[126],"interval":[127],"(CI),":[128],"1.36-5.41;":[129],"comparing":[130],"high":[131],"versus":[132],"low":[133],"COX-2]":[134],"overexpressing":[137],"(HR":[140,166],"2.84;":[142],"CI,":[144,170],"1.07-7.52).":[145],"However,":[146],"hazard":[148],"poor":[150,222],"increased":[154,184],"highest":[157],"among":[158],"patients":[159],"who":[160],"both":[162],"HER2-positive":[165,179,208,246],"5.95;":[168],"1.01-34.9).":[171],"Notably,":[172],"correlated":[181],"two":[191],"targets,":[193],"BAD":[194],"at":[195,199],"Ser136":[196],"Ser196.":[200],"CONCLUSIONS:":[201],"Up-regulation":[202],"activation":[216],"marker":[220],"outcome.":[223],"The":[224],"findings":[225],"suggest":[226],"that":[227],"COX-2-specific":[228],"inhibitors":[229,231],"may":[236],"act":[237],"synergistically":[238],"as":[239],"anticancer":[240],"drugs":[241],"subtype.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}